Overview 2020-03-17T17:08:46+00:00


Research Process Pre-clinical Phase 1 Phase 2 Phase 3
ALT-P1 Long-acting Human Growth Hormone
Domestic Phase II in Progress / Preparation of global Phase II
ALT-Q2 Long-acting Factor Vlla
Process Development in Progress
ALT-P7 Breast/Gastric Cancer ADC
Preparation of Phase II Clinical Trial
ALT-Q5 Ovarian Cancer ADC
Process Development in Progress
ALT-L9 Eylea Biosimilar
First-in-class Domestic Phase I Clinical Trial in Progress
ALT-L2 Herceptin Biosimilar
Preparation of Global Phase III Clinical Trial
ALT-LS2 Herceptin SC Biosimilar
Process Development in Progress